Patent · US Active

Thiazolidine derivatives as orexin receptor antagonists

US8236964B2 · kind B2 · utility

13Cited by

1References

17Claims

0Family size

Assignee

Actelion Pharmaceuticals Ltd. · CH

Inventors

Hamed Aissaoui · Allschwil, CH
Christoph Boss · Allschwil, CH
Markus Gude · Allschwil, CH
Ralf Koberstein · Bad Kötzting, DE
Thierry Sifferlen · Allschwil, CH

Key dates

Filing date	Mar 25, 2008
Grant date	Aug 7, 2012
Priority date	—
Expiry date	Jan 19, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D513/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to novel thiazolidine derivatives of the formula (I) wherein A and R1 are as described in the description and their use as medicaments, especially as orexin receptor antagonists.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.